CCN2 and idiopathic pulmonary fibrosis: Our results reveal a signaling pathway related to ADAM17, CTGF, and FN and can be used to interpret how TGF-β induces the expression of CTGF and EMT, which may provide a new orientation for the treatment of IPF (Figure 9).